Meloxicam pharmacokinetics in renal impairment-Reference-Cited by-同舟云学术

Meloxicam pharmacokinetics in renal impairment

Published:1997-01 Issue:1 Volume:43 Page:35-40
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Boulton-Jones J. M.,Geddes C. G.,Heinzel G.,Türck D.,Nehmiz G.,Bevis P. J. R.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1997.tb00030.x/fullpdf

Reference30 articles.

1. 1G. Engelhardt Meloxicam a potent inhibitor of COX-2. Data presented at 9th International Conference on Prostaglandins and Related Compounds, Florence, Italy1994 , P.82 .

2. Towards a better aspirin

3. New insights into the mode of action of anti-inflammatory drugs

4. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-01-13

2. Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes;Archives of Pharmacal Research;2021-11-22

3. Relative risk of end-stage renal disease requiring dialysis in treated ankylosing spondylitis patients compared with individuals without ankylosing spondylitis: A nationwide, population-based, matched-cohort study;PLOS ONE;2020-04-20

4. Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects;Regional Anesthesia & Pain Medicine;2019-02-07

5. Meloxicam in the management of post-operative pain: Narrative review;Journal of Anaesthesiology Clinical Pharmacology;2018